Aims: This study aims to investigate the relationship between plasma endothelin-1 (ET-1) concentrations, ET-1 gene polymorphisms in loci rs5370, rs1630736, 3A/4A and clinical features of primary nephrotic syndrome (NS) in children. Materials and methods: Thirty-six children with primary NS were selected as case group, and 94 healthy children were selected as control group. All subjects were genotyped for three single nucleotide polymorphisms (SNPs) (rs5370, rs10478694 [3A4A] and rs 1630736) in the ET-1 gene by gene sequencing. The plasma ET-1 concentrations were measured using a radio-immunoassay. Key findings: Plasma ET-1 concentrations were higher in NS patients (P = 0.007) as compared to healthy children. The allele frequencies between control and NS patients were significantly different only with respect to the rs10478694 SNP of the ET-1 gene. The allele frequencies between control and NS patients for the rs5370 SNP showed a trend towards difference (P = 0.057). Plasma cholesterol in NS patients is associated with both: the GT genotype in locus rs5370 and the 3A4A genotype in locus rs10478694 (P b 0.05 in both cases). Significance: The ET systems might play a disease modifying role in pediatric NS. Plasma cholesterol, a hallmark of NS, seems to be associated with genetic variations within the human ET-1 gene.
Introduction
Animal models in which the human ET-1 gene was transferred into the germline of mice were established independently by two research groups (Hocher et al., 1997a,b; Shindo et al., 2002) . Both groups observed similar results: the overexpression of the ET-1 generated a phenotype characterized by the age-dependent, but blood pressure independent development of kidney fibrosis, glomerulosclerosis, renal cysts leading to a progressive decrease in glomerular filtration rate in aged mice. In these transgenic models hypertension can only be induced by salt-loading. This was unexpected since previous studies showed ET-1 to be a potent vasoconstrictor when administered intravenously (Yanagisawa et al., 1988; Hocher et al., 1997a,b) . In rats overexpressing the human ET-2 gene (ET-2 targets the same receptors as ET-1) likewise a blood pressure-independent fibrotic remodeling of the kidney was seen but fibrosis is mainly restricted to the glomeruli. This is most probably due to the preferential expression of the transgene (human ET-2 gene) within the glomeruli in ET-2 transgenic animals and thus indicating that a primarily activated glomerular ET system may cause proteinuria (Hocher et al., 1996) . Glomerular expression of ET-2 caused proteinuria in this model, whereas ET-1 transgenic mice with a moderate glomerular transgene expression do not develop proteinuria.
Defects in the glomerular basement membrane and related cells (for example podocytes) are considered as causal for development of proteinuria in patents with nephrotic syndrome. Based on the work with genetically altered animal models, we hypothesized that genetic alterations of the glomerular ET-system might modify manifestation of the nephrotic syndrome in humans. Genetic association studies in human with NS might support -but clearly not prove -this hypothesis. In line with this concept, it was already reported that ET-1 gene polymorphisms are associated with the morbidity of IgA nephropathy (Maixnerova et al., 2007) and the progression of autosomal dominant polycystic kidney diseases (Reiterova et al., 2006) .
In the current study the following three ET-1 gene polymorphisms were tested: rs5370, rs10478694 (3A4A) and rs 1630736. The functional significance of rs5370 is not clear at this time. Indeed, although the G-to-T transversion induces a nonsynonymous amino acid change in codon 198 of the prepro-ET-1 molecule, codon 198 is cleaved out from the biologically active ET-1 molecule. Alternative causal mechanisms, such as an effect on mRNA stability, must be considered. Recent association studies suggest that the Lys198Asn polymorphism interacts with blood pressure in overweight people, or with body mass index (BMI) in association with hypertension. The 3A/4A polymorphism (rs10478694) of the ET-1 gene has significant functional importance. Expression studies have shown increased luciferase activity of the insertion variant (I) as compared to the wild-type (D) variant and the half-life of mRNA containing the insertion variant is prolonged. In the same study, elevated ET-1 levels were also reported in the insertion variant as compared to wild type. Significant difference in ET-1 levels between 3A/4A and 3A/3A genotypes has also been reported. This ET-1 gene polymorphism is also implicated in increased susceptibility to vasovagal syncope. Much less is known about the rs 1630736 ET-1 SNP. No functional data are available. However, clinical data suggest an association with asthma and left ventricular mass in hypertensive patients (Vasku et al., 2002; Tiret et al., 1999; Sampsonas et al., 2010; Bloch et al., 1989; Pinto-Sietsma et al., 2003; Asai et al., 2001; Treiber et al., 2003; Zhu et al., 2008) ; see Table 4 ).
Kidney diseases are in general rare during childhood. Primary nephrotic syndrome (NS) is -among these rare diseases -a fairly frequent one. Children with NS are usually seen in specialize university pediatric nephrology centers. These patients often present with severe edema, massive proteinuria and hyperlipidemia. Some of the patients are steroid resistant or steroid dependent, which are difficult to treat, but its pathogenesis is still not clear. Previous studies supported that the genetic background may modify disease pathogenesis/severity in primary NS in children. (Lee et al., 1997; Shahid et al., 2012; Hinkes et al., 2007; Kobayashi et al., 1995 Kobayashi et al., , 2003 Kim et al., 2003; Jafar et al., 2011; Zalewski et al., 2008; Obeidová et al., 2012; Haeffner et al., 1997) . We hypothesize that the plasma ET-1 concentrations and the ET-1 gene polymorphisms are associated with the morbidity and the clinical phenotype of the NS in children.
Patients and methods

Patients
We invited a total of 36 Chinese children with primary nephrotic syndrome (NS) at the Pediatrics Department of the First Affiliated Hospital and Zhuhai Hospital of Jinan University. The inclusion criteria were as follows: onset age, b18 years old; patients with proteinuria, ≥ 50 mg/kg ⋅ day; and serum albumin, b30 g/l, excluding secondary NS. Thirty-six children with primary NS formed the case group, including 22 boys and 14 girls. Fourteen cases were steroid resistance NS and 22 cases were non-steroid resistance NS. Twelve cases were with hypertension and 24 cases were with non-hypertension. Renal biopsies were done in 11 patients, of which 3 cases with minimal change disease, 3 cases with membranous glomerulonephritis, 1 case with mesangioproliferative glomerulonephritis and 4 cases with focal segmental glomerulosclerosis. Ninety-four children, whose urinalysis is normal and who have no past history of kidney disease, from a kindergarten in Guangzhou were randomly chosen as gene control, of which 67 children's plasma ET-1 concentrations were measured as a control. At the same time 24 hour urine protein output, the plasma creatinine concentrations, blood urea nitrogen level (BUN) and plasma albumin were measured in NS patients.
Reagent and instruments
DNA was purified from 1.5 ml of blood using the "chlorophenol extraction" method.
Genotyping of the polymorphism in locus rs5370 and rs1630736
The following were the primers used: upstream primer: 5′-TTCCTC AAGGCAGGGTCACA-3′; downstream primer: 5′-GGGGGAACTCCTTAAC CTTTCTTG-3′. PCR reaction system (50 μl) was as follows: the reaction mixture contained 2 μl of genomic DNA, 2 μl of each primer, 4 μl dNTP, 5 μl PCR buffer, 0.25 μl of Taq polymerase (Takara, Biotech, Dalian, China) and double distilled water to a volume of 50 μl. The cycling conditions were as follows: after the initial denaturation at 94°C for 5 minutes, 39 amplification cycles were carried out according to the following temperature profile: 30 s at 94°C, 45 s at 53.7°C, 50 s at 72. The final extension lasted for 5 minutes at 72°C.
Genotyping of the polymorphism in locus 3A/4A
The following primers were used: upstream primer: 5′-CAGACGCG CCTCTGCATCTG-3′; downstream primer: 5′-AGCGTGCCTACCTGTTTC TG-3. PCR reaction system was the same as described above. The cycling conditions were as follows: after the initial denaturation at 94°C for 5 minutes, followed by 39 cycles according to the following temperature profile: 30 s at 94°C, 45 s at 55.4°C, 50 s at 72°C. The final extension lasted for 5 minutes at 72°C. The product of PCR was sequenced by ABI-PRISM 3730 genetic analyzer (Guangzhou Ying-wei biotechnology corporation).
The plasma ET-1 concentrations were measured by a commercial radioimmunoassay (Puvevalley Biotech Company, Beijing, China) according the instructions of the manufacturer. The main technical indicators are: a) sensitivity: 15 pg/ml, b) the standard curve range: 20 pg--200 pg/ml; c) intra-assay coefficient of variation: b7%, coefficient of variation between batches: b12%; d) specificity: the antiserum had no cross-reaction to motilin, osteocalcin, C terminal parathyroid hormone, calcitonin and other peptides; e) normal plasma reference values in healthy volunteers are 50.6 ± 24.5 pg/ml (n = 25).
Statistical analyses
The data are presented as mean ± SD or as a percentage. The chisquare test was used to test differences in genotype and allele frequencies. T test was used to test the differences in plasma ET-1 concentrations in case group and control group. Completely randomized design analysis was used to test the differences of clinical indicators in three different genotypes. P-values b0.05 were considered significant. All statistical analyses were performed using SPSS-PC for Windows, Version 16.0. (SPSS Inc., Chicago, IL, USA).
Results
1.
The descriptive data of case and control group are provided in Table 1 . The mean age between case group and control group is significantly different (5.8 ± 3.59 vs. 4.14 ± 1.12 years). 2. Plasma ET-1 concentrations were significantly different between NS patients and controls (P = 0.007). This was in particular seen in children over the age of 5 years (P = 0.001). Plasma ET-1 concentrations in general decreased with age (see Table 1 ). 3. Plasma ET-1 concentrations were not significantly associated with ET-1 genetic variants analyzed in this study (see Table 2 ). When comparing plasma ET-1 concentrations in the case group by t test, there was no significant differences between the ET-1 plasma concentrations in relationship to ET-1 genetic variants of all three tested SNPs. Similarly, there were no significant differences between the ET-1 plasma concentrations in relationship to ET-1 genetic variants of all three tested SNPs in the control group. This was also seen after adjustment for age, gender, responsiveness to steroids, and hypertension as independent confounding factors. However, cases with the 3A4A genotype in the Rs10478694 locus had higher plasma ET-1 concentrations as compared to controls with the 3A3A genotype in the Rs10478694 locus. Furthermore, cases with the GG genotype in the Rs 5370 locus had higher plasma ET-1 concentrations as compared to controls with the GG genotype in the Rs 5370 locus (see Table 2 ). 4. The allele frequencies between control and NS patients were significantly different with respect to the Rs10478694 (3A4A) SNPs of the ET-1 gene, but not with respect to the rs 1630736 ET-1 SNPs. The allele frequencies between control and NS patients for the rs5370 SNP showed a strong trend for difference (P = 0.057). 5. Plasma cholesterol was significantly (P b 0.05) different when comparing the most frequent genotypes of the rs5370 locus (GG versus GT). Similarly, plasma cholesterol was significantly (P b 0.05) different when comparing the most frequent genotypes of the Rs10478694 locus (3A/3A versus 3A/4A). The rs1630736 SNP was not associated with plasma cholesterol concentrations. Twenty-four hour urine protein output, plasma creatinine, BUN and albumin were not associated with the ET-1 gene SNPs (Table 3) .
Discussion
Primary NS is a common kidney disease in children. Previous studies have described an association between ET-1 gene variations and kidney diseases in adult patients. In the present study, we demonstrated that plasma ET-1 concentrations in pediatric NS patients were significantly higher as compared to healthy children. We showed that the ET-1 gene SNP (rs10478694) correlated with the risk of NS and correlated with plasma ET-1 concentrations when comparing healthy children to children with NS. Moreover, the ET-1 gene SNPs (rs5370 and rs10478694) are 
Allele distributions for the three analyzed ET-1 gene variants are given as raw numbers. Plasma ET-1 concentrations are given as mean ± SD. When comparing plasma ET-1 concentrations within the case group, there were no significant differences between the ET-1 plasma concentrations in relationship to the ET-1 genetic variants of all three tested SNPs. Similarly, there were no significant differences between the ET-1 plasma concentrations in relationship to ET-1 genetic variants within the control group. Cases with the 3A3A genotype in the Rs10478694 locus had higher plasma ET-1 concentrations as compared to controls with the 3A3A genotype in the Rs10478694 locus. Furthermore, cases with the GG genotype in the Rs 5370 locus had higher plasma ET-1 concentrations as compared to controls with the GG genotype in the Rs 5370 locus. a P b 0.05. b P b 0.05. c Two blood samples out of 36 cases were hemolytic and could not be analyzed for ET-1 concentrations. (14) 29.78 ± 8.58 (14) 4.18 ± 1.24 (14) 11.60 ± 3.21 (14) 16.28 ± 6.65(14) 4A/4A 101.01 ± 15.30 (2) 140.00 ± 132.94(2) 4.66 ± 0.34(2) 6.24 ± 5.14(2) 11.00 ± 1.41 (2 Data are given as mean ± SD, genotype numbers are given in break lets. Plasma cholesterol was significantly (P b 0.05) different when comparing the most frequent genotypes of the rs5370 locus (GG versus GT). Similarly, plasma cholesterol was significantly (P b 0.05) different when comparing the most frequent genotypes of the Rs10478694 locus (3A/3A versus 3A/4A). related to the plasma cholesterol level in primary NS of children. Elevated plasma and tissue concentrations of ET-1 have been associated with the development of renal interstitial fibrosis and glomerulosclerosis leading to progressive decrease in glomerular filtration rat (Duan et al., 1999; Vlachojannis et al., 2002; Cottone et al., 2009; Dhaun et al., 2009; Liu et al., 1998) . The ET-1gene was assigned to human chromosome 6, in which 191 polymorphic loci have been reported so far. We analyzed three out of about 200 genetic variants of the ET-1 gene. In the current study the following gene variants of the ET-1 gene were analyzed: rs5370, rs10478694 (3A4A) and rs 1630736 (see Table 4 for details and current knowledge about function and associations to clinical readouts). It was for example reported that ET-1 gene polymorphism influenced the progression of autosomal dominant polycystic kidney diseases (Reiterova et al., 2006) , and they found a significantly lower age of onset of ESRD in the carriers of the 4A allele in combination with the 198N allele in the carriers of the 4A allele homozygous for the K198 allele. We, however, could not demonstrate an association of the ET-1 gene SNPs with markers of disease such as plasma creatinine and BUN in patients with NS. There might be two reasons. Our study is for sure underpowered to show this and more importantly the renal function in terms of GFR in most patients with childhood NS is often normal. Larger adequately powered prospective studies are needed to demonstrate a potential effect of ET-1 gene SNPs on disease progression in pediatric NS. The rs10478694/3A/4A gene polymorphism might affect the transcription of the ET-1 gene (Vasku et al., 2002) . Our results suggested that the plasma ET-1 concentrations are affected by both 3A/4A genotype and the disease. However the mechanism needs further investigations. We failed to demonstrate an association between the difference of the plasma ET-1 concentrations and ET-1 gene polymorphisms in locus rs1630736, maybe because this SNP is functionally less important.
Evidence from both the experiments and clinical studies suggests that high lipid levels are not only a marker of disease, but also contribute to the development of glomerulosclerosis (Kees-Folts and Diamond, 1993) . The report suggests that cholesterol in children with NS plays an important role in the progression of the disease. In our study, plasma cholesterol in NS patients with the GT genotype in locus rs5370 and with the rs10478694/3A4A genotype in locus 3A/4A was higher as compared to other genotypes. The ET-1 gene may modulate lipid metabolism via yet unknown pathways. In transgenic animal models (see Introduction), an activated glomerular ET system causes proteinuria. In humans, it is more likely that the analyzed genetic variants of the ET-1 gene play a disease modifying role rather than a causal role. We need, however, to keep in mind that our study is an association study. Thus this hypothesis needs to be tested in adequately designed basic science experiment able to prove causality.
It is a clear study limitation that controls and cases were not agematched. There was a by chance age difference of 1.64 years. The relatively low number of cases and controls, the lack of urine samples to analyses urinary ET-1 excretion probably more reflecting the renal ETsystem, and the lack of a replication cohort are general study limitations as well. We need to keep in mind that primary pediatric NS is a pretty rare condition in childhood making it practically very difficult to collect huge cohorts. However, since comorbidity is less in children, genetic data coming from these cohorts are less affected by confounding factors. Genetic association studies in adult patients with NS for example are confounded by comorbidity such as preexisting diabetes, hypertension, cardiovascular diseases, and atherosclerosis, background medication, duration of preexisting diseases, and number of preexisting diseases (children with NS just have NS, adults usually suffer beside NS from other diseases as well). Thus even smaller pediatric studies may show clear associations. In any case, our data should be regarded as hypothesis generating study. Another study limitation is the fact that the crossreactivity of the ET-1 assay to ET-2, ET-3, Big-E, Big-ET-1, Big-ET-2, and Big-ET-3 is unknown. This might explain the rather high ET-1 concentrations seen in this study.
Conclusions
This study provides the first evidence of an association between the ET-1 gene SNPs and clinical parameters in nephrotic syndrome of children, potentially adding new insights into the pathophysiology of childhood primary nephrotic syndrome. 
